Adaptive Biotechnologies Corporation (ADPT) vs Definium Therapeutics, Inc. (DFTX)
A side-by-side comparison of Adaptive Biotechnologies Corporation and Definium Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADPT
Adaptive Biotechnologies Corporation
$29.13HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
DFTX
Definium Therapeutics, Inc.
$35.63HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — ADPT vs DFTX
growth of $100 · dividends reinvested · last 7yADPT -26.0% (-4.2%/yr)DFTX +3993.8% (+69.9%/yr)DFTX compounded faster over this window
Log scale — wide-divergence pair
ADPT DFTX
ADPT vs DFTX: by the numbers
- •DFTX is the larger company ($4.73B vs $4.66B market cap).
- •Both run net losses; DFTX's is the smaller (0.00% vs -20.73% net margin).
Metrics side by side
Valuation
| Metric | ADPT | DFTX |
|---|---|---|
| P/S ratio | 15.13 | N/A |
| P/B ratio | 32.62 | 5.15 |
Profitability
| Metric | ADPT | DFTX |
|---|---|---|
| Gross margin | 75.44% | 0.00% |
| Operating margin | -20.62% | 0.00% |
| Net margin | -20.73% | 0.00% |
| ROE | -44.68% | -38.51% |
| ROIC | -6.67% | -23.81% |
Growth (annualized)
| Metric | ADPT | DFTX |
|---|---|---|
| Revenue CAGR (5Y) | 18.22% | N/A |
| Total return CAGR (5Y) | -1.77% | 1.43% |
Frequently asked
- How have ADPT and DFTX total returns compared?
- Over the past 5 years, ADPT delivered -1.77% and DFTX delivered 1.43% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Adaptive Biotechnologies ROEDefinium Therapeutics ROEAdaptive Biotechnologies operating marginDefinium Therapeutics operating marginAdaptive Biotechnologies revenue growthDefinium Therapeutics revenue growthAdaptive Biotechnologies free cash flowDefinium Therapeutics free cash flow
Adaptive Biotechnologies & Definium Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.